BVMFKRSA3
Market cap94mUSD
Dec 23, Last price
8.18BRL
1D
2.89%
1Q
74.04%
IPO
-89.78%
Name
Kora Saude Participacoes SA
Chart & Performance
P/E
—
P/S
0.26
EPS
—
Div Yield, %
0.19%
Shrs. gr., 5y
-36.53%
Rev. gr., 5y
51.39%
Revenues
2.26b
+10.40%
Net income
-168m
L+55.80%
CFO
-232m
L
Profile
Kora Saúde Participações S.A. owns and operates hospitals in Brazil. It has 11 hospitals in Espírito Santo, Tocantins, Mato Grosso, and Federal District. The company was founded in 2001 and is based in Vitória, Brazil.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 2,259,687 10.40% | 2,046,729 62.20% | 1,261,856 44.16% | ||||
Cost of revenue | 1,978,247 | 1,579,143 | 946,568 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 281,440 | 467,586 | 315,288 | ||||
NOPBT Margin | 12.45% | 22.85% | 24.99% | ||||
Operating Taxes | 24,084 | 4,749 | 57,789 | ||||
Tax Rate | 8.56% | 1.02% | 18.33% | ||||
NOPAT | 257,356 | 462,837 | 257,499 | ||||
Net income | (167,624) 55.80% | (107,588) 68.85% | (63,718) -501.47% | ||||
Dividends | (1,107) | (4,432) | |||||
Dividend yield | 0.11% | 0.01% | |||||
Proceeds from repurchase of equity | 855 | (16,536) | 278,399 | ||||
BB yield | -0.09% | 0.27% | -0.90% | ||||
| Debt | |||||||
Debt current | 213,852 | 207,518 | 190,123 | ||||
Long-term debt | 3,268,170 | 2,597,908 | 1,851,038 | ||||
Deferred revenue | 613,562 | 355,337 | |||||
Other long-term liabilities | 388,270 | 29,593 | 3,632 | ||||
Net debt | 3,113,535 | 1,993,243 | 1,620,884 | ||||
| Cash flow | |||||||
Cash from operating activities | (231,715) | 281,356 | 15,388 | ||||
CAPEX | (91,241) | (132,355) | (99,109) | ||||
Cash from investing activities | (108,644) | (442,011) | (1,748,040) | ||||
Cash from financing activities | (79,317) | 543,220 | 1,948,848 | ||||
FCF | (116,078) | 121,478 | (386,055) | ||||
| Balance | |||||||
Cash | 359,858 | 779,534 | 396,969 | ||||
Long term investments | 8,629 | 32,649 | 23,308 | ||||
Excess cash | 255,503 | 709,847 | 357,184 | ||||
Stockholders' equity | 1,152,262 | 1,192,021 | 1,325,639 | ||||
Invested Capital | 3,962,852 | 3,509,722 | 2,940,941 | ||||
ROIC | 6.89% | 14.35% | 10.51% | ||||
ROCE | 6.67% | 11.07% | 9.40% | ||||
| EV | |||||||
Common stock shares outstanding | 77,320 | 775,872 | 593,427 | ||||
Price | 13.00 66.67% | 7.80 -84.97% | 51.90 | ||||
Market cap | 1,005,161 -83.39% | 6,051,802 -80.35% | 30,798,861 | ||||
EV | 4,217,397 | 8,130,773 | 32,494,199 | ||||
EBITDA | 449,011 | 591,656 | 388,557 | ||||
EV/EBITDA | 9.39 | 13.74 | 83.63 | ||||
Interest | 376,397 | 292,416 | 106,467 | ||||
Interest/NOPBT | 133.74% | 62.54% | 33.77% | ||||